INOVIO PHARMACEUTICALS, INC.
Company Stats
- Market Cap
- $126.1M
- as of Sep 30, 2026
- Shares Outstanding
- 103.4M
- Free Float
- 98.9%
Income Statement
- Revenue
- $65,343
- Operating Income
- -$86.8M
- Net Income
- -$84.9M
- EBITDA
- -$85.4M
- Revenue Growth, 3Y
- -81.5%
- FCF Margin, 3Y Avg
- -66359.9%
- FCF Margin, Worst Year
- -136074.5%
Cash Flow
- Free Cash Flow
- -$88.9M
- FCF Yield
- -70.5%
- Owner FCF Yield
- -73.5%
Balance Sheet
- Cash & Equivalents
- $44.3M
Returns & Capital
- SBC, 3Y Avg
- $7.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $65,343 | -$88.9M | -136074.5% |
| FY2024 | $217,756 | -$104.6M | -48019.1% |
| FY2023 | $832,010 | -$124.7M | -14986.2% |
| FY2022 | $10.3M | -$217.2M | -2116.3% |
| FY2021 | $1.8M | -$216.9M | -12223.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 27, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.